期刊文献+

胆汁酸与冠心病的关系 被引量:6

下载PDF
导出
摘要 冠状动脉发生粥样硬化导致管腔狭窄甚至闭塞是几乎所有冠心病(CHD)的病因。目前大多数研究表明,动脉粥样硬化最主要的危险因素之一是脂类代谢异常。脂类代谢异常的类型较多,以总胆固醇(TC)和低密度脂蛋白胆固醇(LDL—C)升高最受关注。大量研究表明TC和LDL—C升高与CHD相关,CHD患者通过强化调脂治疗可明显获益。
出处 《临床医药实践》 2016年第8期612-614,共3页 Proceeding of Clinical Medicine
  • 相关文献

参考文献13

  • 1CHIANG J Y. Regulation of bile acid synthesis : path- ways, nuclear receptors, and mechanisms [ J ]. Hepatol, 2004,40 (3) :539 - 551.
  • 2查锡良.生物化学[M].7版.北京:人民卫生出版社,2013:419—423.
  • 3张久聪,聂青和.胆汁酸代谢及相关进展[J].胃肠病学和肝病学杂志,2008,17(11):953-956. 被引量:49
  • 4GARNER C M, MILLS C O, ELIAS E, et al. The effect of bile salts on human vascular endothelial cells [ J ]. Biochem Biophys Acta, 1991,109 ( 1 ) :41 - 45.
  • 5MAK P A, KAST -WOELBERN H R, ANISFELD A M, et al. Identification of PLTP as an FXR target reveals overlapping targets for the two nuclear receptors [ J ]. Lipid Res ,2002,43 ( 1 ) :2 037 - 2 041.
  • 6REPA J J, LUND E G, HORTON J D, et al. Disruption of the sterol 27 - hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia. Reversal by cholic acid feeding [ J ]. BiolChem, 2000,275 ( 50 ) : 39 685 -39 692.
  • 7LAFFIrI'FE B A, REPA J J, JOSPEPH S B, et al. LXRs control lipid - inducible expression of apolipo - protein E gene in maerophages and adipose tissue [ J ]. Proe NatL Acad Sei USA,2001,98(2) :507 -512.
  • 8CHARACH G, RABINOVICH P D, KONIKOFF F M, et al. Deereased fecal bile acid output in patients with cor- onary atherosclerosis [ J ]. Journal of Medicine, 1998,29 (3 -4) :125 - 136.
  • 9CHARACH G, GROSSKOPF I, RABINOVICH A, et al. The association of bile acid excretion and atherosclero- 0sis coronary artery disease [ J ]. Therapeutic Advances in Gastroenterology, 2011,4 (2) : 95 - 101.
  • 10RAJARATNAM R A, GYLLING H, MIETHNEN T A. Cholesterol absorption, synthesis, and fecal output in postmenopausal women with and without coronary artery disease[ J ]. Arterioscler Thromb Vase Biol, 2001,21 (10) : 1 650 - 1 655.

二级参考文献23

  • 1聂青和,张亚飞.胆汁酸代谢[J].肝脏,2004,9(4):247-249. 被引量:12
  • 2Alrefai WA, Gill RK. Bile acid transporters: structure, function, regulation and pathophysiological implications [ J ]. Pharm Res, 2007,24 (10) : 1803-1823.
  • 3Chiang JY. Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms [J]. J Hepatol, 200d, 40(3): 539-551.
  • 4Crosignani A, Del Puppo M, Longo M, et al. Changes in classic and alternative pathways of bile acid synthesis in chronic liver disease [ J]. Clin Chim Acta, 2007, 382 (1-2) : 82-88.
  • 5Nilsson LM, Abrahamsson A, Sahlin S, et al. Bile acids and lipoprotein metabolism: effects of cholestyramine and chenodeoxycholic acid on human hepatic mRNA expression [J]. Biochem Biophys Res Commun, 2007, 357(3) : 707-711.
  • 6Davis M. Cholestasis and endogenous opioids: liver disease and exogenous opioid pharmacokinetics [ J ]. Clin Pharmacokinet, 2007, 46 (10) : 825-850.
  • 7Houten SM, Watanabe M, Auwerx J. Endocrine functions of bile acids [J]. EMBO J, 2006, 25(7): 1419-1425.
  • 8Kullak-Ublick GA, Stieger B, Meier PJ. Enterohepatic bile salt transporters in normal physiology and liver disease [ J ]. Gastroenterology, 2004, 126( 1 ) : 322-342.
  • 9Lo Sasso G, Petruzzelli M, Moschetta A. A translational view on the biliary lipid secretory network [ J ]. Biochim Biophys Acta, 2008, 1781(3) : 79-96.
  • 10Anwer MS. Cellular regulation of hepatic bile acid transport in health and cholestasis [ J]. Hepatology, 2004, 39 (3) : 581-590.

共引文献60

同被引文献67

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部